PreveCeutical Medical Inc. (CSE: PREV)

Market Cap	8.13M
Revenue (ttm)	n/a
Net Income (ttm)	-1.26M
Shares Out	541.70M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0150
Previous Close	0.0200
Day's Range	0.0150 - 0.0150
52-Week Range	0.0150 - 0.0300
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 21, 2024

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and o...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Stephen Van Deventer
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PREV